BMX — BioMaxima SA Cashflow Statement
0.000.00%
Last trade - 00:00- PLN61.85m
- PLN76.79m
- PLN53.88m
- 77
- 36
- 64
- 64
Annual cashflow statement for BioMaxima SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | PAS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 7.36 | 12.8 | 35.9 | 0.187 | 0.306 |
| Depreciation | |||||
| Non-Cash Items | 0.465 | 0.192 | -0.384 | 0.47 | 0.972 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5.75 | -14.8 | -0.44 | -1.55 | -4.79 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 3.97 | -0.132 | 37.1 | 1.59 | -0.152 |
| Capital Expenditures | -1.88 | -4.48 | -9.88 | -18.1 | -2.27 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.231 | 1.11 | 2.05 | 0.831 | 1.51 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.65 | -3.37 | -7.83 | -17.2 | -0.759 |
| Financing Cash Flow Items | 0.16 | -0.169 | -0.467 | -0.578 | -1.16 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.48 | 2.11 | -19.3 | 4.25 | 0.317 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.8 | -1.39 | 9.91 | -11.4 | -0.594 |